Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21991949 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Observation of Medical Treatments in MBC HER2-negative Patients
Condition: Metastatic Breast Cancer
Intervention: Other: Observation of treatment management
2 Active, not recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: doxorubicine, cyclophosphamide, docetaxel;   Drug: doxorubicine, cyclophosphamide, trastuzumab, docetaxel;   Drug: trastuzumab, docetaxel, carboplatin

Indicates status has not been verified in more than two years